IVVD
NASDAQ
$0.69
Invivyd Inc (IVVD)
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases in the United States. The company is headquartered in Waltham, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $10 (+1359.21%)
Market Cap
$231M
Free Cash Flow Yield
-34.39%
Beta (5Y)
1.32
Price Chart
Valuation
Market Cap$231M
Forward P/E44.64
P/S4.31
P/B1.16
Profitability
Total Revenue (TTM)$56M
Gross Profit (TTM)$52M
EBITDA-$78M
Profit Margin-138.9%
Operating Margin-313.9%
EPS-$0.36
Financial Health
Free Cash Flow Yield-34.39%
Growth & Risk
Beta (5Y)1.32
Sharpe Ratio0.54